Jiangsu Hualan New Pharmaceutical Material Co.,Ltd. (SHE:301093)
China · Delayed Price · Currency is CNY 81.90
-4.41 (-5.11%)
Feb 11, 2026, 4:00 PM EST
SHE:301093 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 |
Net Income | 50.65 | 49.57 | 117.93 | 93.75 | 216.02 | 81.36 |
Depreciation & Amortization | 55.84 | 55.84 | 44.45 | 34.84 | 28.11 | 29.45 |
Other Amortization | 18.73 | 18.73 | 17.77 | 18.58 | 12.64 | 10.22 |
Loss (Gain) From Sale of Assets | -0 | -0 | -0.21 | -0.24 | -0 | -1.76 |
Asset Writedown & Restructuring Costs | 0.05 | 0.05 | 0.04 | 0.81 | 0.02 | 2.17 |
Loss (Gain) From Sale of Investments | -21.93 | -21.93 | -48.62 | -34.96 | - | - |
Provision & Write-off of Bad Debts | 0.45 | 0.45 | -1.04 | 1.58 | 2.39 | - |
Other Operating Activities | -46.68 | 2.91 | 0.01 | 2.22 | 6.54 | 6.9 |
Change in Accounts Receivable | 14.69 | 14.69 | -10.74 | -17.91 | -72.4 | -14.93 |
Change in Inventory | -36.28 | -36.28 | 23.61 | 12.23 | -47 | 3.77 |
Change in Accounts Payable | 4.3 | 4.3 | 30.1 | -29.5 | 67.13 | 15.99 |
Change in Other Net Operating Assets | 34.8 | 34.8 | 57.75 | 10.24 | 2.44 | 0.58 |
Operating Cash Flow | 72.27 | 120.78 | 223.85 | 94.88 | 216.54 | 133.4 |
Operating Cash Flow Growth | -66.41% | -46.05% | 135.93% | -56.18% | 62.32% | 55.91% |
Capital Expenditures | -135.63 | -135.43 | -297.25 | -173.62 | -123.76 | -39.54 |
Sale of Property, Plant & Equipment | 0.57 | 0.03 | 0.42 | 1.14 | 0.4 | 2.66 |
Investment in Securities | 288.64 | 234.28 | 365.04 | -1,524 | - | - |
Other Investing Activities | 23.42 | 46.57 | 36.71 | 11.09 | -1.19 | - |
Investing Cash Flow | 177 | 145.46 | 104.92 | -1,685 | -124.55 | -36.88 |
Short-Term Debt Issued | - | - | 20 | - | 131.8 | 192.43 |
Total Debt Issued | - | - | 20 | - | 131.8 | 192.43 |
Short-Term Debt Repaid | - | - | -20 | - | -211.93 | -217.8 |
Long-Term Debt Repaid | - | -0.48 | - | -40.38 | - | - |
Total Debt Repaid | -0.48 | -0.48 | -20 | -40.38 | -211.93 | -217.8 |
Net Debt Issued (Repaid) | -0.48 | -0.48 | - | -40.38 | -80.13 | -25.37 |
Issuance of Common Stock | 136.4 | 11.15 | 12.28 | - | 1,955 | - |
Repurchase of Common Stock | -230.65 | -230.65 | -27 | - | - | - |
Common Dividends Paid | -25.35 | -77.65 | -40.93 | -94.9 | -4.47 | -52.01 |
Other Financing Activities | 121.85 | - | - | - | -147.55 | -4.33 |
Financing Cash Flow | 1.77 | -297.63 | -55.66 | -135.28 | 1,723 | -81.71 |
Foreign Exchange Rate Adjustments | 1.02 | 0.13 | 1.26 | -0.35 | -1.7 | -0.37 |
Net Cash Flow | 252.05 | -31.27 | 274.37 | -1,726 | 1,814 | 14.45 |
Free Cash Flow | -63.37 | -14.65 | -73.39 | -78.73 | 92.78 | 93.86 |
Free Cash Flow Growth | - | - | - | - | -1.15% | 68.36% |
Free Cash Flow Margin | -10.48% | -2.50% | -11.78% | -13.48% | 11.30% | 21.03% |
Free Cash Flow Per Share | -0.39 | -0.09 | -0.41 | -0.45 | 0.67 | 0.71 |
Cash Income Tax Paid | 21.13 | 39.5 | 40.62 | 34.69 | 80.41 | 37.51 |
Levered Free Cash Flow | 514.67 | -37.44 | -125.09 | -100.43 | 33.66 | 49.86 |
Unlevered Free Cash Flow | 515.18 | -37.29 | -124.81 | -100.05 | 36.68 | 54.11 |
Change in Working Capital | 15.15 | 15.15 | 93.53 | -21.69 | -49.18 | 5.07 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.